Image For Activity Cover
CardioBites:HFpEF
CardioBites: What is Heart Failure with Preserved Ejection Fraction (HFpEF) and Who Does it Impact
Heart failure with preserved ejection fraction or (HFpEF) is defined as the symptoms and/or signs of heart failure caused by structural/functional cardiac abnormalities. It also includes at least one of the following: elevated natriuretic peptides; or objective evidence of cardiogenic pulmonary or systemic congestion. Learn more about the diagnosis and treatment of this challenging condition.
Videos in the HFpEF Series

What is Heart Failure with Preserved Ejection Fraction (HFpEF) and Who Does It Impact?
Heart failure with preserved ejection fraction or (HFpEF) is defined as the symptoms and/or signs of heart failure caused by structural/functional cardiac abnormalities. It also includes at least one of the following: elevated natriuretic peptides; or objective evidence of cardiogenic pulmonary or systemic congestion. Learn more about the diagnosis and treatment of this challenging condition.  Watch now

What is the Clinical Workup for Diagnosing Heart Failure with Preserved Ejection Fraction (HFpEF)?
Accurate, early evaluation and diagnosis of heart failure with preserved ejection fraction (HFpEF) facilitates treatment intervewntions and improves outcomes.  In this CardioBites, we review the clinical workup for diagnosing HFpEF.  Watch now


What are the phenotypes of Heart Failure with Preserved Ejection Fraction (HFpEF)?
Our third program on HFpEF examines clinical phenotypes, comorbidities, and some underlying differences in pathophysiology. Learn more about how identifying the underlying phenotype of HFpEF may facilitate a more targeted approach to treatment. Watch now

What Do Current Guidelines Recommend for Treatment of HFpEF
The goals of therapy for patients with heart failure with preserved ejection fraction are to reduce HF symptoms, increase functional status, and reduce the risk of hospital admission. Learn more about the current guidelines and therapeutics for the treatment of these challenging patients. Watch now

Subscribe to the HFSA YouTube Channel
pdf document link
Subscribe to the HFSA YouTube channel.
Supporter(s)
Funding support provided by Novo Nordisk.  Novo Nordisk did not reveiw the content.
Summary
Cost:
FREE
Credit:
No Credit Offered
Powered by Oasis.